中國服飾控股(01146.HK)2021年淨虧1.52億元 同比擴大24.2%
格隆匯3月21日丨 中國服飾控股(01146.HK)公吿,截至2021年12月31日止年度全年業績,收入3.23億元,同比減少55.6%;母公司擁有人應占虧損1.52億元,同比擴大24.2%;每股基本虧損4.62分。
公司主要於中國大城市的百貨公司及商場的自營零售點將產品零售予終端客户,銷售產品予第三方零售商(其直接管理公司在中國並無營運零售點的其他城市的特許專櫃及零售店舖),以及通過線上渠道銷售產品,從而產生收入。
收入按扣除貿易折扣後的已售貨品發票淨值列賬。收入下降乃主要由於Jeep品牌商品銷售減少,因Jeep品牌授權許可協議已於2020年12月31日終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.